Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
Holding ANIP?
Track your performance easily
ANIP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$48.20 - $70.81
Previous Close$60.51
Volume409.93K
Average Volume (3M)284.77K
Market Cap
$1.28B
Enterprise Value$1.32B
Total Cash (Recent Filing)$240.11M
Total Debt (Recent Filing)$285.24M
Price to Earnings (P/E)49.5
Beta0.86
Next Earnings
Nov 06, 2024EPS Estimate
$1.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.22
Shares Outstanding21,030,069
10 Day Avg. Volume389,311
30 Day Avg. Volume284,766
Standard Deviation0.12
R-Squared0.10
Alpha-0.00241
Financial Highlights & Ratios
Price to Book (P/B)3.98
Price to Sales (P/S)1.80
Price to Cash Flow (P/CF)14.00
P/FCF Ratio13.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.25
Enterprise Value/Gross Profit7.45
Enterprise Value/Ebitda13.96
Forecast
1Y Price Target
$94.00Price Target Upside55.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
ANI Pharmaceuticals News
Bulls Say, Bears Say
Bulls Say
Financial ForecastThe company meaningfully raised their sales and earnings guidance for FY 2023.
Financial PerformanceANIP delivered record quarterly net revenues, EBITDA and EPS that were above expectations.
Product PerformanceThe stock reacted very positively to exceptionally strong Cortrophin Gel performance.
Bears Say
Earnings Call ImpactStock has faced significant pressure since their earnings call.
Management GuidanceInvestors are concerned due to management's comments related to softening specific market opportunities.
Sales PerformanceThe established brands segment declined dramatically.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ANIP FAQ
What was ANI Pharmaceuticals Inc’s price range in the past 12 months?
ANI Pharmaceuticals Inc lowest stock price was $48.20 and its highest was $70.81 in the past 12 months.
What is ANI Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is ANI Pharmaceuticals Inc’s upcoming earnings report date?
ANI Pharmaceuticals Inc’s upcoming earnings report date is Nov 06, 2024 which is in 59 days.
How were ANI Pharmaceuticals Inc’s earnings last quarter?
ANI Pharmaceuticals Inc released its earnings results on Aug 06, 2024. The company reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.07.
Is ANI Pharmaceuticals Inc overvalued?
According to Wall Street analysts ANI Pharmaceuticals Inc’s price is currently Undervalued.
Does ANI Pharmaceuticals Inc pay dividends?
ANI Pharmaceuticals Inc does not currently pay dividends.
What is ANI Pharmaceuticals Inc’s EPS estimate?
ANI Pharmaceuticals Inc’s EPS estimate is $1.1.
How many shares outstanding does ANI Pharmaceuticals Inc have?
ANI Pharmaceuticals Inc has 21,030,070 shares outstanding.
What happened to ANI Pharmaceuticals Inc’s price movement after its last earnings report?
ANI Pharmaceuticals Inc reported an EPS of $1.02 in its last earnings report, beating expectations of $0.95. Following the earnings report the stock price went up 6.981%.
Which hedge fund is a major shareholder of ANI Pharmaceuticals Inc?
Among the largest hedge funds holding ANI Pharmaceuticals Inc’s share is Hussman Strategic Advisors Inc. It holds ANI Pharmaceuticals Inc’s shares valued at 3M.
---
ANI Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$94.00 (55.35% Upside)
$94.00 (55.35% Upside)
Blogger Sentiment
Bullish
ANIP Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 21.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.6%
Last 30 Days ▲ 5.0%
Last 30 Days ▲ 5.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.22%
12-Months-Change
Fundamentals
Return on Equity
5.66%
Trailing 12-Months
Asset Growth
7.15%
Trailing 12-Months
Company Description
ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
---
ANIP Earnings Call
Q2 2024
0:00 / 0:00
---
ANIP Stock 12 Month Forecast
Average Price Target
$94.00
▲(55.35% Upside)
Technical Analysis
Dr Reddy's Laboratories
―
Harrow Health
―
Bausch Health Companies
―
Amphastar Pharmaceuticals
―
Best Analysts Covering ANIP
1 Year
1 Year Success Rate
7/11 ratings generated profit
1 Year Average Return
+23.62%
reiterated a buy rating last month
Copying Oren Livnat's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +23.62% per trade.
---